NCT04643925View on ClinicalTrials.gov

hCG Priming in Women With Low Ovarian Reserve

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 27, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Infertility, FemaleOvarian ReserveIn Vitro Fertilization
Interventions
DRUG

Ovitrelle

Ovitrelle 260 IE once daily for 8 weeks prior to IVF/ICSI

Trial Locations (1)

2100

Rigshospitalet, København Ø

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT04643925 - hCG Priming in Women With Low Ovarian Reserve | Biotech Hunter | Biotech Hunter